Edmonds Duncan Registered Investment Advisors, LLC Exact Sciences Corp Transaction History

Edmonds Duncan Registered Investment Advisors, LLC

$446 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 11, 2024	BUY	$59.06 - $75.72 $7,146 - $9,162	121 Added 3.67%	3,415 $252,000
Q3 2023 Oct 16, 2023	SELL	$65.94 - $99.04 $11,077 - $16,638	-168 Reduced 4.85%	3,294 $224,000
Q2 2023 Jul 06, 2023	BUY	$62.68 - $95.05 $6,894 - $10,455	110 Added 3.28%	3,462 $325,000
Q1 2023 Apr 12, 2023	BUY	$47.19 - $70.77 $158,180 - $237,221	3,352 New	3,352 $227,000

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

Vanguard Group Inc Valley Forge, PA

17.8M
Shares

$1.02 Billion
0.02% of portfolio
Capital World Investors Los Angeles, CA

15.8M
Shares

$911 Million
0.17% of portfolio
Wellington Management Group LLP Boston, MA

14.3M
Shares

$824 Million
0.18% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$694 Million
0.01% of portfolio
State Street Corp Boston, MA

6.68M
Shares

$384 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmonds Duncan Registered Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edmonds Duncan Registered Investment Advisors, LLC with notifications on news.

Account